— Know what they know.
Not Investment Advice

KVUE NYSE

Kenvue Inc.
1W: -0.6% 1M: -2.5% 3M: -9.2% YTD: +0.2% 1Y: -27.5% 3Y: -28.5%
$17.32
+0.17 (+0.96%)
 
Weekly Expected Move ±2.4%
$16 $17 $17 $18 $18
NYSE · Consumer Defensive · Household & Personal Products · Alpha Radar Sell · Power 44 · $32.9B mcap · 1.92B float · 1.17% daily turnover · Short 41% of daily vol
Smart Money Score
Bullish 75
Insider+$111.0M
Congress1 trades
ETF Holdings
Key Statistics
Market Cap$32.9B
52W Range14.02-24.355
Volume14,316,832
Avg Volume22,505,026
Beta0.52
Dividend$0.83
Analyst Ratings
4 Buy 10 Hold 0 Sell
Consensus Hold
Company Info
CEOKirk L. Perry
Employees22,000
SectorConsumer Defensive
IndustryHousehold & Personal Products
IPO Date2023-05-04
Websitekenvue.com
1 Kenvue Way
Summit, NJ 07901
US
908 874 1200
About Kenvue Inc.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Recent Insider Trades

NameTypeSharesPriceDate
Orlando Matthew S-Sale 38,491 $17.66 2026-05-08
Smith Jeffrey C A-Award 1,331 2026-03-30
ALLISON RICHARD E JR A-Award 1,331 2026-03-30
Stevens Meredith M-Exempt 4,329 2026-03-10
Stevens Meredith M-Exempt 840 2026-03-10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms